0001264124-12-000057.txt : 20120224 0001264124-12-000057.hdr.sgml : 20120224 20120224170211 ACCESSION NUMBER: 0001264124-12-000057 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120222 FILED AS OF DATE: 20120224 DATE AS OF CHANGE: 20120224 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gergen Mark J CENTRAL INDEX KEY: 0001373110 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19700 FILM NUMBER: 12638969 MAIL ADDRESS: STREET 1: 9360 TOWNE CENTRE DR CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMYLIN PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000881464 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 330266089 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9360 TOWNE CENTRE DR STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 6195522200 MAIL ADDRESS: STREET 1: 9360 TOWNE CENTRE DR STREET 2: SUITE 110 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 edgardoc.xml PRIMARY DOCUMENT X0304 4 2012-02-22 0 0000881464 AMYLIN PHARMACEUTICALS INC AMLN 0001373110 Gergen Mark J 9360 TOWNE CENTRE DR SAN DIEGO CA 92121 0 1 0 0 SVP, Corporate Development Common Stock 2012-02-22 4 A 0 20000 0 A 62344.2 D Common Stock 2012-02-23 4 S 0 7518 17.0302 D 54826.2 D Common Stock 2609 I Indirect-401k Common Stock 6445.1 I by ESOP Represents shares acquired upon vesting of performance-based restricted stock units. Sale of common shares to satisfy reporting person's income tax withholding obligations due upon vesting of performance-based restricted stock units. These shares fully vested four years from the date of the reporting person's participation in the ESOP in four equal annual installments and are generally distributed upon termination of employment. By: /s/ James R. Oehler, Attorney-in-Fact For: Mark J. Gergen 2012-02-24